A Second-Generation AR Bifunctional Degrader for Drug-Resistant Prostate Cancer
ARV-766
oral AR-degrading PROTAC Ph. II for adv. prostate cancer from CRBN-based E3 recruiter + AR ligand AACR, April 2023 Arvinas, New Haven, CT
Loading...
oral AR-degrading PROTAC Ph. II for adv. prostate cancer from CRBN-based E3 recruiter + AR ligand AACR, April 2023 Arvinas, New Haven, CT